Assignee
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD
CN·22 granted patents·14 pending applications·17 citations·filing 2015–2022
Top patents by PatentIndex Score
36 records- 0184US12540138B2Substituted oxaspiro[4.5]decanes as MOR receptor agonistsSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2021·Granted Feb 3, 2026·1 cites·22 claims
- 0282US10100047B2Piperidine derivatives as orexin receptor antagonistSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 16, 2018·5 cites·10 claims
- 0379US12545680B2Substituted oxaspiro[4.5]decanes as mor receptor agonistsSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2021·Granted Feb 10, 2026·1 cites·17 claims
- 0479US10815197B2N-sulfonyl benzamides as voltage-gated sodium channel inhibitorsSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Oct 27, 2020·2 cites·2 claims
- 0578US11155546B24,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Oct 26, 2021·1 cites·19 claims
- 0677US10435400B22,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefromSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 8, 2019·3 cites·9 claims
- 0772US10577346B2Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Mar 3, 2020·1 cites·19 claims
- 0867US10912775B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Feb 9, 2021·0 cites·7 claims
- 0966US10561646B2EGFR inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Feb 18, 2020·1 cites·15 claims
- 1065US10874674B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Dec 29, 2020·0 cites·5 claims
- 1164US10898486B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Jan 26, 2021·0 cites·6 claims
- 1263US10227324B22-morpholin-4,6-disubstituted pyrimidine derivative, and preparation method and pharmaceutical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Mar 12, 2019·1 cites·24 claims
- 1363US9879008B22,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Jan 30, 2018·1 cites·10 claims
- 1458US10947202B2Sodium ion channel inhibitors and pharmaceutically acceptable salts and polymorphs thereof and uses thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2019·Granted Mar 16, 2021·0 cites·9 claims
- 1556US11174254B2Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2018·Granted Nov 16, 2021·0 cites·12 claims
- 1655US2024287026A1Triazinylmethylcycloalkylcarboxylic acid derivative, and pharmaceutical composition and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 1753US10668066B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Jun 2, 2020·0 cites·7 claims
- 1853US2024109898A1Substituted pyrazolo[1,5-a]pyrimidine-7-amine derivatives, compositions and pharmaceutical uses thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 1952US2024025924A1Heterocycle substituted ketone derivative, and composition and medicinal use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 2052US2024376081A1Polymorph and application of pyrimidine derivative and pharmaceutically acceptable salt thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 2149US2023145793A1Substituted pyrimidine or pyridine amine derivative, composition thereof, and medical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 2249US2024109895A1Oxaspiro substituted pyrrolopyrazole derivative, intermediate thereof, and preparation method thereforSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 2348US2023149402A1Solid pharmaceutical preparation, preparation method therefor and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 2447US2021386721A1Substituted phenylpropenyl pyridine derivatives, their preparation and pharmaceutical applicationsSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 2546US2024317761A1Pharmaceutically acceptable salt of mor receptor agonist, and polymorph thereof and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 2643US2020262813A11,5,7-trisubstituted isoquinoline derivatives, preparation thereof, and use thereof in medicinesSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Application pending·0 cites
- 2740US11168088B2Pyridylamino substituted heterotricyclic compounds, and preparation method and pharmaceutical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Nov 9, 2021·0 cites·20 claims
- 2837US11104664B24,5,6-trisubstituted indazole derivatives, and preparation method and pharmaceutical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Aug 31, 2021·0 cites·14 claims
- 2937US2021214358A1Cdk4/6 inhibitor and pharmaceutically acceptable salt and polymorph thereof and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2019·Application pending·0 cites
- 3036US2021188813A1Ezh2 inhibitor and pharmaceutically acceptable salts and polymorphic substances thereof, and application of ezh2 inhibitorSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2019·Application pending·0 cites
- 3135US10793549B2Sulfuryl-substituted benzoheterocyclic derivative, preparation method and medical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Oct 6, 2020·0 cites·18 claims
- 3235US10085983B2Azabicyclo derivatives, process for preparation thereof and medical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 2, 2018·0 cites·13 claims
- 3335US2021395247A1Btk inhibitors, pharmaceutically acceptable salts, polymorphs and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 3433US9890168B22,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Feb 13, 2018·0 cites·20 claims
- 3531US10544137B2PI3K inhibitor, and pharmaceutically acceptable salt, polycrystalline form, and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Jan 28, 2020·0 cites·7 claims
- 3629US2021087156A1Pharmaceutically acceptable salts of benzodicycloalkane derivative, polymorphic substance thereof, and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →